Also interesting
GMP certification for Exothera further extends its viral vector manufacturing capacity
Exothera achieves GMP certification and extends its facilities by a further 2,100 m² (22,600 ft²) production bringing the total capacity to 8,600 m² (92,570 ft²) for viral vector development and manufacturing...
Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
The new facility audited and accredited by Belgian Authorities will allow the production and the purification of up to 10 g scale ( up to 1 Million doses of vaccine)...
Takeda says yes to Belgium with a new sustainable biotechnology production facility in Lessines
At the end of August, Takeda inaugurated a new production facility at its global manufacturing site in Lessines, Belgium. The inauguration ceremony was attended by government officials as well as representatives of public authorities, industry and patient organizations...